Skip to Content

Apacross 5 mg / ml powder for dispersion for infusion

Licence status
Authorised: 26/09/2025
Active substances
Paclitaxel
Dosage Form
Powder for dispersion for infusion
Licence number
PA22766/015/001
Licence holder
Seacross Pharma (Europe) Limited

Licence information

ATC code
L01CD01 paclitaxel
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (See: Summary of Product Characteristics, section 4.2)
Marketing availability
Not marketed
Advertising conditions
Advertising to healthcare professionals only
Licence issued
26/09/2025